HuangBBachmannKHeX. Inappropriate prescriptions for the aging population of the United States: an analysis of the National Ambulatory Medical Care Survey, 1997. Pharmacoepidemiol Drug Saf2002;11:127–34.
2.
ZedPAbu-LabanRBalenRIncidence, severity and preventability of medication - related visits to the emergency department: a prospective study. CMAJ2008;178:1563–9.
3.
Blueprint for pharmacy: the vision for pharmacy. Ottawa (ON): Canadian Pharmacists Association; 2008.
4.
TsuyukiRTJohnsonJATeoKKStudy of cardiovascular risk intervention by pharmacists (SCRIP): a randomized trial design of the effect of a community pharmacist intervention program on serum cholesterol risk. Ann Pharmacother1999;33:910–9.
5.
BerryTMProsserTRWilsonKAsthma friendly pharmacies: a model to improve communication and collaboration among pharmacists, patients, and healthcare providers. J Urban Health2011;88(Suppl 1):113–25.
6.
HorsfieldESheridanJAndersonC. What do community pharmacists think about undertaking screening and brief interventions with problem drinkers? Results of a qualitative study in New Zealand and England. Int J Pharm Pract2011;19:192–200.
7.
DoucetteWNevinsJMcDonoughR. Factors affecting collaborative care between pharmacists and physicians. Res Social Adm Pharm2005;1:565–78.
8.
BradleyFElveyRAshcroftDThe challenge of integrating community pharmacists into the primary health care team: a case study of local pharmaceutical services (LPS) pilots and interprofessional collaboration. J Interprof Care2008;4:387–98.
9.
PapaioannouAMorinSCheungAM2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ2010;182:1864–73.
10.
FRAX: Fracture risk assessment tool. World Health Organisation. Available: www.shef.ac.uk/FRAX/tool.jsp (accessed Feb. 26, 2012).
